14h
Zacks Investment Research on MSNABT Stock to Gain From Early CE Mark Approval of Volt PFA SystemAbbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...
A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...
23h
MedPage Today on MSNSotatercept Helps the Sickest Patients With Pulmonary Arterial HypertensionAdding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk patients ...
SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results